Questa pagina è stata tradotta automaticamente e l'accuratezza della traduzione non è garantita. Si prega di fare riferimento al Versione inglese per un testo di partenza.

Effects of Resistance Exercise Timing on Midday Muscle Performance in Athletes

23 settembre 2026 aggiornato da: Manisa Celal Bayar University

Time-Course Effect of Post-Activation Performance Enhancement on Midday Peak Torque and Muscle Activation

This study investigated whether the timing of a resistance-based post-activation performance enhancement (PAPE) intervention performed during the morning influences muscle performance and muscle electrical activity during a standardized midday assessment in trained male athletes. Participants completed a control condition and three PAPE conditions performed at different times during the morning. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises. In all conditions, muscle performance was assessed between 12:00 and 12:15 using an isokinetic dynamometer, while surface electromyography (sEMG) of the rectus femoris muscle was recorded. The study compared relative peak torque and sEMG spectral power across the different PAPE timing conditions and the control condition.

Panoramica dello studio

Stato

Completato

Condizioni

Intervento / Trattamento

Tipo di studio

Interventistico

Iscrizione (Effettivo)

13

Fase

  • Non applicabile

Contatti e Sedi

Questa sezione fornisce i recapiti di coloro che conducono lo studio e informazioni su dove viene condotto lo studio.

Luoghi di studio

      • Manisa, Turchia (Türkiye), 45040
        • Manisa Celal Bayar University, Faculty of Sport Sciences

Criteri di partecipazione

I ricercatori cercano persone che corrispondano a una certa descrizione, chiamata criteri di ammissibilità. Alcuni esempi di questi criteri sono le condizioni generali di salute di una persona o trattamenti precedenti.

Criteri di ammissibilità

Età idonea allo studio

  • Bambino
  • Adulto
  • Adulto più anziano

Accetta volontari sani

Sì

Sessi ammissibili allo studio

Maschio

Descrizione

Inclusion Criteria:

  • Regularly participating in systematic sport-specific training (minimum training age of 3 years)
  • Able to comply with pre-testing restrictions (avoidance of intense physical activity for 72 hours and caffeine for 2 hours prior to testing sessions)

Exclusion Criteria:

  • Any musculoskeletal, orthopedic, or health condition preventing safe participation in maximal isokinetic exercise testing
  • Current or recent injury affecting lower-limb strength or performance testing

Piano di studio

Questa sezione fornisce i dettagli del piano di studio, compreso il modo in cui lo studio è progettato e ciò che lo studio sta misurando.

Come è strutturato lo studio?

Dettagli di progettazione

  • Scopo principale: Scienza basilare
  • Assegnazione: Randomizzato
  • Modello interventistico: Assegnazione incrociata
  • Mascheramento: Nessuno (etichetta aperta)

Armi e interventi

Gruppo di partecipanti / Arm
Intervento / Trattamento
Nessun intervento: Control (C)

Participants completed the standardized midday isokinetic performance assessment without a PAPE intervention. The assessment consisted of four maximal repetitions on an isokinetic dynamometer at 60°·s-¹ between 12:00 and 12:15, while rectus femoris surface electromyography was recorded.

Sperimentale: PAPE T1

Participants performed the standardized PAPE intervention between 08:00 and 09:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Sperimentale: PAPE T2

Participants performed the standardized PAPE intervention between 10:00 and 11:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Sperimentale: PAPE T3

Participants performed the standardized PAPE intervention between 11:45 and 12:00 before the midday performance assessment. The PAPE intervention consisted of back squat, kettlebell swing, and barbell hip thrust exercises, with one set of six repetitions at 80% of the individual estimated one-repetition maximum (e1RM) for each exercise and a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute cycling warm-up at 60 rpm and 5 minutes of passive rest.

The resistance-based PAPE intervention consisted of three exercises performed in the following order: back squat, kettlebell swing, and barbell hip thrust. Participants performed one set of six repetitions at 80% of their individual estimated one-repetition maximum (e1RM) for each exercise, with a 1-minute rest interval between exercises. The intervention was preceded by a 5-minute standardized cycling warm-up at 60 rpm followed by 5 minutes of passive rest. The same PAPE protocol was performed in the T1, T2, and T3 conditions at different times before the standardized midday performance assessment.

Cosa sta misurando lo studio?

Misure di risultato primarie

Misura del risultato
Misura Descrizione
Lasso di tempo
Relative Peak Torque (RPT)
Lasso di tempo: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Relative peak torque (RPT) was determined from the highest peak torque value obtained during four maximal knee extension repetitions performed on an isokinetic dynamometer at 60°·s-¹. Peak torque was normalized to body mass and expressed as N·m·kg-¹.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.
Rectus Femoris sEMG Spectral Power
Lasso di tempo: Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Surface electromyography (sEMG) of the rectus femoris muscle was recorded during the maximal isokinetic knee extension repetitions. Spectral power was calculated from the processed sEMG signal using fast Fourier transform (FFT) analysis and expressed as µV²/Hz.

Measured once per condition (control, T1, T2, T3) at a fixed assessment time (12:00-12:15 PM). PAPE was performed 3.5 hours (T1), 1.5 hours (T2), or immediately (T3) before assessment. Each condition was separated by at least 48 hours.

Collaboratori e investigatori

Qui è dove troverai le persone e le organizzazioni coinvolte in questo studio.

Sponsor

Studiare le date dei record

Queste date tengono traccia dell'avanzamento della registrazione dello studio e dell'invio dei risultati di sintesi a ClinicalTrials.gov. I record degli studi e i risultati riportati vengono esaminati dalla National Library of Medicine (NLM) per assicurarsi che soddisfino specifici standard di controllo della qualità prima di essere pubblicati sul sito Web pubblico.

Studia le date principali

Inizio studio (Effettivo)

3 giugno 2025

Completamento primario (Effettivo)

20 agosto 2025

Completamento dello studio (Effettivo)

15 settembre 2025

Date di iscrizione allo studio

Primo inviato

15 settembre 2026

Primo inviato che soddisfa i criteri di controllo qualità

23 settembre 2026

Primo Inserito (Effettivo)

25 settembre 2026

Aggiornamenti dei record di studio

Ultimo aggiornamento pubblicato (Effettivo)

25 settembre 2026

Ultimo aggiornamento inviato che soddisfa i criteri QC

23 settembre 2026

Ultimo verificato

1 settembre 2026

Maggiori informazioni

Termini relativi a questo studio

Altri numeri di identificazione dello studio

  • MCBU_PAPE_2025

Piano per i dati dei singoli partecipanti (IPD)

Hai intenzione di condividere i dati dei singoli partecipanti (IPD)?

NO

Descrizione del piano IPD

Individual participant data are not planned to be publicly shared due to participant confidentiality and data protection considerations.

Informazioni su farmaci e dispositivi, documenti di studio

Studia un prodotto farmaceutico regolamentato dalla FDA degli Stati Uniti

No

Studia un dispositivo regolamentato dalla FDA degli Stati Uniti

No

Queste informazioni sono state recuperate direttamente dal sito web clinicaltrials.gov senza alcuna modifica. In caso di richieste di modifica, rimozione o aggiornamento dei dettagli dello studio, contattare register@clinicaltrials.gov. Non appena verrà implementata una modifica su clinicaltrials.gov, questa verrà aggiornata automaticamente anche sul nostro sito web .